Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $182.21 million as of August 25, 2026. Its market cap has increased by 3,846.60% in one year.
Market Cap
182.21M
Enterprise Value
93.59M
1-Year Change
3,846.60%
Ranking
Category
Stock Price
$63.40
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $182.21M, a decrease of -51.86%. That is a compound annual growth rate of -11.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 182.21M | 95.42% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 157.56M |
| Unicycive Therapeutics | 156.83M |
| Tenaya Therapeutics | 156.36M |
| NRx Pharmaceuticals | 154.02M |
| Kazia Therapeutics | 153.18M |
| Aardvark Therapeutics | 149.25M |
| Milestone Pharmaceuticals | 148.66M |
| Connect Biopharma Holdings | 148.62M |